BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/15/2017 6:16:31 AM | Browse: 1322 | Download: 1695
 |
Received |
|
2017-01-22 10:29 |
|
Peer-Review Started |
|
2017-01-22 16:53 |
|
To Make the First Decision |
|
2017-02-10 08:48 |
|
Return for Revision |
|
2017-02-13 12:59 |
|
Revised |
|
2017-02-19 04:11 |
|
Second Decision |
|
2017-03-09 13:21 |
|
Accepted by Journal Editor-in-Chief |
|
2017-03-12 17:48 |
|
Accepted by Executive Editor-in-Chief |
|
2017-03-15 10:01 |
|
Articles in Press |
|
2017-03-15 10:01 |
|
Publication Fee Transferred |
|
2017-04-12 15:01 |
 |
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2017-04-22 16:12 |
|
Publish the Manuscript Online |
|
2017-05-15 06:16 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Evidence-Based Medicine |
| Article Title |
Antimicrobial susceptibility testing before first-line treatment for Helicobacter pylori infection in patients with dual or triple antibiotic resistance
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Angel Cosme, Milagrosa Montes, Begoña Ibarra, Esther Tamayo, Horacio Alonso, Usua Mendarte, Jacobo Lizasoan, Marta Herreros-Villanueva and Luis Bujanda |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dr. Luis Bujanda, Gastroenterology Department, Hospital Universitario Donostia/Instituto Biodonostia, Universidad del País Vasco, Centro de Investigación Biomédica en Red de Enfermedades Hepaticas y Digestivas, Paseo Dr. Beguiristain s/n, 20014 San Sebastián,
Spain. medik@telefonica.net |
| Key Words |
Helicobacter pylori; Resistance; Eradication rate; Antimicrobial susceptibility; Therapies |
| Core Tip |
This study evaluated the efficacy of antimicrobial susceptibility-guided therapy: proton-pump inhibitor and two or three antibiotics for ten days before first-line treatment in patients with dual or triple Helicobacter pylori resistance to clarithromycin, metronidazole and/or levofloxacin. Intention to treat analysis demonstrates that eradication rates in patients with dual Helicobacter pylori resistance are high (around 95%). Cure rate was significantly higher in naive patients with dual resistance compared to those with triple resistance (95% vs 83%). |
| Publish Date |
2017-05-15 06:16 |
| Citation |
Cosme A, Montes M, Ibarra B, Tamayo E, Alonso H, Mendarte U, Lizasoan J, Herreros-Villanueva M, Bujanda L. Antimicrobial susceptibility testing before first-line treatment for Helicobacter pylori infection in patients with dual or triple antibiotic resistance. World J Gastroenterol 2017; 23(18): 3367-3373 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i18/3367.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i18.3367 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
